Key facts
- This page summarizes Adam K. Stern's Form 4 filing for DarioHealth Corp. (DRIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Jan 2025, 16:04.
Adam K. Stern - 07 Jan 2025 Form 4 Insider Report for DarioHealth Corp. (DRIO)
- Reporting relationship
- Director
- Issuer ticker
- DRIO
- Reported as of
- 07 Jan 2025
- Net transaction value
- +$100,000
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2025, 16:04:16 UTC
- Prior SEC filing
- 09 Aug 2024
- Next SEC filing
- 10 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adam Stern
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Adam K. Stern filed Form 4 for DarioHealth Corp. (DRIO) on 10 Jan 2025.
Change
- Previous filing in this sequence was filed on 09 Aug 2024.
- Current net transaction value: +$100,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DRIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 194,341
- Date
- 07 Jan 2025
- Ownership
- Direct
DRIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 122,909
- Date
- 07 Jan 2025
- Ownership
- AKS Family Partners L.P.
DRIO
holding
Series-C Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 123,763
- Date
- 07 Jan 2025
- Ownership
- AKS Family Partners L.P.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DRIO
transaction
Derivative
Series D-2 Preferred Stock
Purchase
- Transaction value
- $100,000
- Shares
- +100
- Change %
- Price
- $1000.00
- Shares after
- 0
- Date
- 07 Jan 2025
- Ownership
- AKS Family Partners L.P.
- Underlying class
- Common Stock
- Underlying amount
- Exercise price
- $0.8300
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.